Bone Marrow MicroRNA-335 Level Predicts the Chemotherapy Response and Prognosis of Adult Acute Myeloid LeukemiaYingchun Li, Rong Zhang, Ying Yang|Medicine|2015Cited by 21
Interim results of PDL1V (PF-08046054), a vedotin-based ADC targeting PD-L1, in patients with NSCLC in a phase 1 trial.Elisa Fontana, Ramy Saleh, Aakash Desai et al.|Journal of Clinical Oncology|2025Cited by 2
Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxisCheng Hu, Yongxin Sun, Chenxia Zhou et al.|Proceedings of the National Academy of Sciences|2025Cited by 2